146 related articles for article (PubMed ID: 22327936)
1. Oncogenic MAP2K1 mutations in human epithelial tumors.
Choi YL; Soda M; Ueno T; Hamada T; Haruta H; Yamato A; Fukumura K; Ando M; Kawazu M; Yamashita Y; Mano H
Carcinogenesis; 2012 May; 33(5):956-61. PubMed ID: 22327936
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.
Sai E; Miwa Y; Takeyama R; Kojima S; Ueno T; Yashiro M; Seto Y; Mano H
Cancer Sci; 2019 Aug; 110(8):2643-2651. PubMed ID: 31222839
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
4. Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy.
Gannon HS; Kaplan N; Tsherniak A; Vazquez F; Weir BA; Hahn WC; Meyerson M
Mol Cancer Res; 2016 Feb; 14(2):207-15. PubMed ID: 26582713
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
[TBL] [Abstract][Full Text] [Related]
6. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a new scirrhous gastric carcinoma cell line with microsatellite instability.
Koyama T; Yashiro M; Matsuoka T; Sunami T; Ohira M; Hirakawa K
Oncol Rep; 2004 Aug; 12(2):317-21. PubMed ID: 15254696
[TBL] [Abstract][Full Text] [Related]
8. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus.
Murahashi K; Yashiro M; Takenaka C; Matsuoka T; Ohira M; Chung KH
Int J Oncol; 2001 Nov; 19(5):1029-33. PubMed ID: 11605005
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
12. Invasion activating caveolin-1 mutation in human scirrhous breast cancers.
Hayashi K; Matsuda S; Machida K; Yamamoto T; Fukuda Y; Nimura Y; Hayakawa T; Hamaguchi M
Cancer Res; 2001 Mar; 61(6):2361-4. PubMed ID: 11289096
[TBL] [Abstract][Full Text] [Related]
13. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
[TBL] [Abstract][Full Text] [Related]
14. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
16. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
18. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
[TBL] [Abstract][Full Text] [Related]
19. Novel models for human scirrhous gastric carcinoma in vivo.
Takemura S; Yashiro M; Sunami T; Tendo M; Hirakawa K
Cancer Sci; 2004 Nov; 95(11):893-900. PubMed ID: 15546507
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis and progression of scirrhous carcinoma].
Naito Y; Kino I
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2364-70. PubMed ID: 7944478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
